Masahisa Onoguchi

Frequency analyses of CSF flow on cine MRI in normal pressure hydrocephalus

Abstract. Our objective was to clarify intracranial cerebrospinal fluid (CSF) flow dynamics in normal-pressure hydrocephalus (NPH). Frequency analyses of CSF flow measured with phase-contrast cine MRI were performed. The CSF flow spectra in the aqueduct were determined in patients (n=51) with NPH, brain atrophy or asymptomatic ventricular dilation (VD), and in healthy volunteers (control group; n=25). The changes in CSF flow spectra were also analyzed after intravenous injection of acetazolamide. Moreover, a phase transfer function (PTF) calculated from the spectra of the driving vascular pulsation and CSF flow in the aqueduct were assessed. These values were compared with the pressure volume response (PVR). The amplitude in the NPH group was significantly larger than that in the VD or control group because of a decrease in compliance. The phase in the NPH group was significantly different from that in either the VD or the control group, but no difference was found between the VD and control groups. The amplitude increased in all groups after acetazolamide injection. The PTF in the NPH group was significantly larger than in the control group, and a positive correlation was noted between PTF and PVR. Frequency analyses of CSF flow measured by cine MRI make it possible to noninvasively obtain a more detailed picture of the pathophysiology of NPH.

Prototype imaging protocols for monitoring the efficacy of iodine-131 ablation in differentiated thyroid cancer.

Whole-body and single photon emission tomography (SPET) images during sodium iodide-131 (Na131I) ablation are useful to confirm the efficacy of ablation using 131I imaging. However, there have been no attempts to improve the quality of 131I imaging. We therefore investigated imaging protocols for 131I imaging in differentiated thyroid cancer (DTC). Phantoms containing 131I were used to simulate extra-thyroid beds and thyroid beds. To simulate extra-thyroid beds, a phantom containing 0.19, 0.37, 0.74 or 1.85 MBq was placed in the acquisition center. To simulate the thyroid beds, four phantoms were applied as normal thyroid tissue, and four phantoms containing 0.19, 0.37, 0.74 and 1.85 MBq were arranged around normal thyroid tissue as a cancer. Whole-body imaging was performed at different table speeds, and SPET data acquired with various pixel sizes were reconstructed using a filtered backed projection (FBP) and ordered-subsets expectation maximization with 3-dimensional (OSEM-3D) algorithm. We measured full width at half maximum (FWHM) and % coefficient of variation (%CV). Patients were then examined based on the results of phantom studies. In extrathyroid beds, slower table speed in whole-body imaging improved %CV, but had little effect on FWHM. For SPET imaging OSEM-3D produced high-resolution and low-noise images, and FWHM and %CV improved with smaller pixel size, as compared with FBP. In the thyroid beds, only the 1.85 MBq phantom could be confirmed on whole-body imaging. Images by SPET had high FWHM and low %CV when the smaller pixel size and OSEM-3D were applied. Accumulation of ≤1.85 MBq was detected with a smaller pixel size of ≤4.8 mm and OSEM-3D. For Na131I ablation imaging, slower scan speed is suitable for whole-body imaging and smaller pixel size and OSEM-3D is appropriate for SPET imaging. In conclusion, we confirmed Na131I accumulation in thyroid beds using slower scan speed (≤15 cm/min) on whole-body imaging, and then accurate identification of Na131I accumulation using SPET and CT fusion imaging with smaller pixel size (≤4.8 mm) and OSEM-3D.

Clinical approach to renal study incidental to 99mTc-MDP bone scintigraphy.

In order to investigate the feasibility of the assessment of renal function with99mTc-MDP, we compared renographical images, renogram patterns and the glomerular filtration rate (GFR) obtained by means of a modified Gates’ method and 200 MBq of99mTc-MDP with those obtained by means of99mTc-DTPA. Because 19 of 20 patients had malignant tumors in the genitourinary tract, there was no difference between the two tracers in identifying a parenchymal defect corresponding to renal cancer. Of eight patients with hydronephrosis, four had a defect or decreased uptake with a dilated pelvis, whereas the other four had marked radioisotope retention in the renal pelvis or the whole kidney on serial images. There was also no difference between the two tracers in identifying hydronephrosis. Of 38 paired renograms 35 showed the same renogram patterns with both tracers. Of three patients with different renogram patterns, two had hydronephrosis. In 20 patients including three patients with bone metastasis, total GFR and split GFR obtained with both tracers correlated with a correlation coefficient of r=0.920 (p<0.001) and r=0.944 (p<0.001), respectively. Excluding bone metastasis from the analysis, a linear-regression analysis showed excellent agreement between the two measurements with a correlation coefficient of r=0.960 (p<0.001) and r=0.963 (p<0.001), respectively. The linear regression equations were Y=1.009X −0.111 and Y=1.034X−0.714, respectively. In conclusion,99mTc-MDP can be used as a supplement to evaluate renal function incidental to the survey of bone metastases in patients with malignant tumor.

Comparison of99mTc-tetrofosmin uptakes on planar images with those in excised rats organs with those in excised rats organs

The radioactivity in the organs adjacent to the heart causes interference with the quantitative assessment of myocardial uptake of tracer on scintigraphy. In order to investigate how much the functions of these organs affect myocardial uptake seen in imaging, we compared the myocardial uptake measured by means of a gamma camera with the actual activity in the excised organs.Methods: Thirty-three rats were imaged at 5, 10, 15, 30, 45, 60, 90 and 120 min after the administration of99mTc-tetrofosmin, and % injected dose per pixel (%ID/pixel) for each organ was assessed on planar images (PI measurement). Percent injected dose per gram of tissue (%ID/g) in the heart as well as lungs, liver, gastrointestines and blood was measured by means of a well scintillation counter (WC measurement). Comparison between PI and WC measurements was performed with % uptake, the PI-to-WC ratio and heart-to-organ ratios.Results: Our WC measurement showed an increase in cardiac uptake until 30 min (1.67±0.31%) postinjection and subsequent gradual decrease, whereas PI measurement showed maximum activity of 1.81±0.52% at 15 min postinjection. There was a prominent difference between the two measurements, particularly at 10 min, with a PI/WC ratio of about 1.6 times. Our WC measurement showed maximum pulmonary uptake at 15 min (0.87±0.31%) and a gradual decrease over 15 min, whereas PI measurement showed maximum uptake at 10 min (1.14±0.38%). There was hardly any variation in activity observed later than at 10 min. Our WC measurement showed hardly any variance in hepatic activity from 5 min (0.77±0.19%) to 30 min (0.69±0.27%) with a subsequent gradual decrease. The percent uptake in PI measurement was generally greater than that in WC measurement, and high values were found at 10 min and 15 min with PI/WC ratios of about 3.3 times and 2.3 times, respectively.Conclusion: Percent uptakes in PI measurement were greater than those in WC measurement. The difference between the two measurements was prominent in the early phases. The cardiac uptake in PI measurement was significantly greater than that in WC measurement at 10 min. It was considered that this discrepancy between the two measurements was caused by the Compton scatter from the organs adjacent to the heart.